Table 1.
Analyses | Reference interval | 90% confidence interval | Subjects (n) | Outliers (n) | |
---|---|---|---|---|---|
2.5th–97.5th | 2.5th | 97.5th | |||
WBC (109/L) | 5.0–10.8 | 4.9–5.2 | 10.4–11.7 | 119 | 1 |
Lymph (%) | 15.0–48.0 | 14.0–19.0 | 43–53 | 119 | 1 |
Lymph (109/L) | 1.3–3.7 | 1.2–1.4 | 3.3–4.1 | 119 | 1 |
Neut (%) | 37.0–72.0 | 33.0- 41.0 | 67.0–76.0 | 120 | — |
Neut (109/L) | 2.4–7.5 | 2.3–2.5 | 6.6–8.0 | 119 | 1 |
Mono (%) | 7. 0–13.0 | 6.5–7.5 | 13.0–15.0 | 118 | 2 |
Mono (109/L) | 0.4–1.4 | 0.3–0.5 | 1.1–1.5 | 118 | 2 |
Eo (%) | 0.9–7.7 | 0.8–1.2 | 7.0–7.8 | 114 | 6 |
Eo (109/L) | 0.05–0.55 | 0.04–0.08 | 0.53–0.87 | 118 | 2 |
Baso (%) | 0.4–1.8 | 0.3–0.4 | 1.5–1.9 | 117 | 3 |
Baso (109/L) | 0.02–0.11 | 0.01–0.03 | 0.11–0.15 | 120 | — |
PLT (109/L) | 141–305 | 133–153 | 284–320 | 120 | — |
MPV (fL) | 9.8–13.4 | 9.7–10.1 | 13.0–13.7 | 120 | — |
IPF (%) | 2.0–10.4 | 1.7–2.2 | 9.9–11.8 | 119 | 1 |
RBC (1012/L) | 4.77–5.72 | 4.74–4.84 | 5.57–5.77 | 118 | 2 |
Ht (%) | 40.6–47.4 | 39.4–41.0 | 46.6–48.9 | 120 | — |
Hb (g/L) | 133–162 | 132–135 | 158–163 | 118 | 2 |
MCV (fL) | 80.0–89.5 | 79.5–80.7 | 88.6–91.2 | 118 | 2 |
MCH (pg) | 26–30.0 | 24–26 | 30-31 | 120 | — |
MCHC (g/L) | 32–35 | 31–32 | 34–35 | 119 | 1 |
RDW (%) | 12.4–14.9 | 12.4–12.7 | 14.7–15.2 | 119 | 1 |
RDW-SD (fL) | 38–45 | 37–38 | 44–46 | 120 | — |
RET (%) | 0.54–1.33 | 0.5-0.6 | 1.2–1.4 | 120 | — |
RET (109/L) | 28–68 | 24–30 | 64–75 | 120 | — |
IRF (%) | 3–14 | 2.7–3.6 | 11.5–15.0 | 119 | 1 |
Ret-He (pg) | 32.2–39.2 | 31.6–33.0 | 38.5–39.4 | 119 | 1 |